Shiv Tiwari

Dr. Tiwari's research bona fides include over 6,000 citations in more than 25 publications, making him one of the most cited authors in plant and animal sciences. The highly regarded cell and developmental biologist also has more than a dozen patents, including a Corteva (DuPont Pioneer) one that empowered rapid regeneration and transformation in hardy corn varieties, which helped advance maize product development in the seed industry.

He is a seasoned biotechnology executive, recently serving as CEO/CTO at GreenVenus. There, he led the startup from concept to commercial readiness, leading the charge on regulatory approvals and field trials. Prior to his work at GreenVenus, Tiwari was a senior leader in venture capital, corporate strategy, and R&D. He's brought his scientific depth and leadership presence to companies including venture capital and private equity firm Third Security, synthetic biology business Intrexon, Mendel Biotechnology, and Corteva (DuPont Pioneer).

Dr. Tiwari has lectured and taught at the University of Missouri, Northeastern, and the Chinese Academy of Agricultural Sciences. Shiv earned his Ph.D. in Life Sciences as well as an MBA with high honors from Boston University.